Manufacturing News and Research

RSS
NET study: New theranostic approach effective in reducing tumor volume and extending lifespan

NET study: New theranostic approach effective in reducing tumor volume and extending lifespan

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

Researchers use aroma diffuser for assessing the fit of face masks

Researchers use aroma diffuser for assessing the fit of face masks

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study

Researchers design new chemical tool with high configurational stability, catalytic activity

Researchers design new chemical tool with high configurational stability, catalytic activity

Hazardous chemicals in plastics threaten human health

Hazardous chemicals in plastics threaten human health

Environmental monitoring shows SARS-CoV-2 contamination of surfaces in food plants

Environmental monitoring shows SARS-CoV-2 contamination of surfaces in food plants

Researchers develop new technology for efficient production of monoclonal antibodies

Researchers develop new technology for efficient production of monoclonal antibodies

SLS and Eppendorf to supply ultra-low temperature freezers for UK COVID-19 vaccines

SLS and Eppendorf to supply ultra-low temperature freezers for UK COVID-19 vaccines

UHN gave first COVID-19 vaccine in Canada

UHN gave first COVID-19 vaccine in Canada

Custom Design and Manufacture of Specialist Microplates

Custom Design and Manufacture of Specialist Microplates

Annual Legionella Conference to address major health crisis

Annual Legionella Conference to address major health crisis

Effective adoption of digital technology underpins businesses’ response to COVID-19

Effective adoption of digital technology underpins businesses’ response to COVID-19

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

Tomatoes could become a new, natural source of Parkinson's disease drug

Tomatoes could become a new, natural source of Parkinson's disease drug

Developing antimicrobial products with resistance to coronavirus

Developing antimicrobial products with resistance to coronavirus

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

Amilorides reduce SARS-CoV-2 viral replication in vitro

Amilorides reduce SARS-CoV-2 viral replication in vitro

High-performance ELISA for serology in mild-moderate non-hospitalized COVID-19

High-performance ELISA for serology in mild-moderate non-hospitalized COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.